$-0.20
(Market cap
$618 Mln
Revenue (TTM)
$253 Mln
P/E Ratio
--
P/B Ratio
1.8
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.1 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
48.5
-
Debt to Equity
0.3
-
Book Value
$--
-
EPS
$-1.7
-
Face value
--
-
Shares outstanding
26,109,788
10 Years Aggregate
CFO
$-132.91 Mln
EBITDA
$-66.35 Mln
Net Profit
$-131.09 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Orthopediatrics Corp (KIDS)
| 28.4 | 12.9 | 36.9 | 6.7 | -15.8 | -20.4 | -- |
|
BSE Sensex*
| -9.2 | -1.5 | 3.0 | -4.1 | 5.6 | 5.9 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Orthopediatrics Corp (KIDS)
| -23.4 | -28.5 | -18.2 | -33.6 | 45.1 | -12.2 | 34.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Orthopediatrics Corp (KIDS)
|
22.8 | 617.5 | 252.7 | -39.7 | -8.9 | -11.5 | -- | 1.8 |
| 61.7 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.7 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 59.0 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 179.5 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.8 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 90.1 | 5,403.2 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 322.8 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 172.9 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 |
Shareholding Pattern
View DetailsAbout Orthopediatrics Corp (KIDS)
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.... The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana. Read more
-
President of Scoliosis
Mr. Gregory A. Odle
-
President of Scoliosis
Mr. Gregory A. Odle
-
Headquarters
Warsaw, IN
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Orthopediatrics Corp (KIDS)
What is the current share price of Orthopediatrics Corp (KIDS) Today?
The share price of Orthopediatrics Corp (KIDS) is $22.80 (NASDAQ) as of 02-Sep-2026 16:00 EDT. Orthopediatrics Corp (KIDS) has given a return of -15.76% in the last 3 years.
What is the current PB & PE ratio of Orthopediatrics Corp (KIDS)?
Since, TTM earnings of Orthopediatrics Corp (KIDS) is negative, P/E ratio is not available.
The P/B ratio of Orthopediatrics Corp (KIDS) is 1.77 times as on 28-Aug-2026, a 53 discount to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-10.56 |
1.21 |
2024 |
-14.20 |
1.51 |
2023 |
-35.28 |
1.96 |
2022 |
709.76 |
2.36 |
2021 |
-71.07 |
5.13 |
What is the 52 Week High and Low of Orthopediatrics Corp (KIDS)?
The 52-week high and low of Orthopediatrics Corp (KIDS) are Rs 26.74 and Rs 14.42 as of 03-Sep-2026.
What is the market cap of Orthopediatrics Corp (KIDS)?
Orthopediatrics Corp (KIDS) has a market capitalisation of $ 618 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Orthopediatrics Corp (KIDS)?
Before investing in Orthopediatrics Corp (KIDS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.